… medicine, and cancer therapeutics [1]. Immunotherapy such as adoptive cell transfer (ACT),
and immune checkpoint inhibitors (ICIs), is a type of cancer therapy, taking advantage of …

… of various immune checkpoint inhibitors are summarized, while the interactive mechanism
and recent progress of ICBT-based synergistic therapies with other immunotherapy, …

… Immune checkpoint inhibitors (ICIs) are a class of therapeutic agents that target the key
regulatory molecules governing the response of the immune system to cancer. (14−17) ICIs such …

… -PD1 drugs for the highly mutated cancers linked to a mismatch DNA repair deficiency (microsatellite
instability) 8 . This is a rare example in the history of cancer therapy that a drug was …

… As one of the most eminent eras in the context of tumor immunotherapy, immune-checkpoint
inhibitors (ICIs) have engendered remarkable therapeutic outcomes as a result of their …

… Significant milestones in the development of cancer immune checkpoint inhibitors. Abbreviations:
cd28, cluster of differentiation 28; CTLA-4, cytotoxic T lymphocyte-associated protein 4; …

… For this reason, we propose keeping anti-TNF-α inhibitors as the primary prevention
therapy in both AS and PsA. Upon the initial diagnosis of cancer, we recommend switching to …

… checkpoint inhibitor therapy—neither for treating physicians who want to avoid the overlapping
immune checkpoint inhibitor… are unsuitable for immune checkpoint inhibitor therapy. First, …

… clinical development of checkpoint inhibitors in the treatment of metastatic TNBC will be
discussed, including clinical outcomes with monotherapy and combination therapy regimens, …

… axes, resulting in the evolution of immune checkpoint inhibitors (ICIs). Then, ICIs have … ICIs
based therapies can be practical and rational therapeutic approaches to treat cancer patients. …